Effect Of Abhaya VatakaIn The Management OfFatty Liver Disease.
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2024/07/069931
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Subjects, diagnosed with NAFLD according to the USG report, standard criteria accepted by the American Gastroenterology Association.
Subjects diagnosed with Grade I & II Non Alcoholic Fatty liver Disease Subjects between the age of 18 and 60 years
Subjects irrespective of gender and socio-economic status.
Subjects who are willing to sign the consent form and agreeing to follow the
protocol of the study.
1) Subjects with history of alcohol intake more than 20 g/ day for women and more than 30g/day for men
2) Diagnosed case of renal, respiratory, cardiovascular (including IHD), neurologic diseases, Hepatocellular carcinoma, and liver cirrhosis.
3) Subjects with history of following drug intake -steroids, synthetic estrogens, heparin, and amiodarone, valproic acid, antiviral agents.
4) Pregnant women, lactating mothers and mentally challenged persons.
5) Uncontrolled Diabetes Mellitus and Hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method